bit.bio launches stem cell line for neuro research and screening
Drug Discovery World
NOVEMBER 21, 2023
Biotechnology company bit.bio has launched a range of immune cells to provide researchers with a consistently functional and rapid human in vitro model for the study of neuroinflammation and neurodegenerative diseases. The company’s ioMicroglia cell range is designed to recapitulate key human microglia functions and as such, can mediate inflammatory responses, dispose of unwanted materials, and carry out immune surveillance.
Let's personalize your content